Locally Advanced Breast Cancer in Young Women in Latin America

Overview

Journal Ecancermedicalscience

Specialty Oncology

Date 2019 Feb 23

PMID 30792811

Citations 8

Authors

Cynthia Villarreal-Garza

Edna A Lopez-Martinez

Jose Felipe Munoz-Lozano

Karla Unger-Saldana

Affiliations

Soon will be listed here.

Abstract

The purpose of this review is to organise, summarise and critically assess existing knowledge on locally advanced breast cancer (LABC) among young women in Latin America. We discuss the most relevant findings in six sections: 1) epidemiology of breast cancer in young women in Latin America; 2) being young as a factor for worse prognosis; 3) LABC in young women in the region; 4) aggressive tumour behaviour among young women; 5) delays in diagnosis and treatment and 6) burden of advanced disease. We point out the need to dedicate resources to enhance earlier diagnosis and prompt referrals of young women with breast cancer; promote research regarding prevalence, biologic characteristics, outcomes and reasons for diagnosis and treatment delays for this age group; and finally, implement supportive care programmes as a means of improving patients and their families' well-being. The recognition of the current standpoint of breast cancer in young patients across the continent should shed some light on the importance of this pressing matter.

Citing Articles

A nomogram for predicting overall survival of breast cancer with regional lymph node metastasis in young women.

Sun R, Huang Y, Chen X, Jia H Transl Cancer Res. 2024; 13(2):542-557.

PMID: 38482426 PMC: 10928604. DOI: 10.21037/tcr-23-1825.

Association of and GLUR4 Ion Transporters with Neoadjuvant Chemoresistance in Luminal Locally Advanced Breast Cancer.

Justo-Garrido M, Lopez-Saavedra A, Alcaraz N, Cortes-Gonzalez C, Onate-Ocana L, Caro-Sanchez C Int J Mol Sci. 2023; 24(22).

PMID: 38003293 PMC: 10670992. DOI: 10.3390/ijms242216104.

Breast cancer survival in Mexico between 2007 and 2016 in women without social security: a retrospective cohort study.

Unger-Saldana K, Bandala-Jacques A, Huerta-Gutierrez R, Zamora-Munoz S, Hernandez-Avila J, Cabrera-Galeana P Lancet Reg Health Am. 2023; 23:100541.

PMID: 37408951 PMC: 10319338. DOI: 10.1016/j.lana.2023.100541.

[Associating prognostic factors with clinical results in locally advanced breast cancer].

Ramirez-Torres N, Reyes-Lopez A, Hernandez-Valencia M Rev Med Inst Mex Seguro Soc. 2022; 61(1):88-98.

PMID: 36542781 PMC: 10395981.

Understanding system barriers and facilitators in transnational clinical cancer research: The value of rapid and multimodal ethnographic inquiry.

Bright K Front Sociol. 2022; 7:991183.

PMID: 36530449 PMC: 9751659. DOI: 10.3389/fsoc.2022.991183.

References

Richards M, Smith P, Ramirez A, Fentiman I, Rubens R . The influence on survival of delay in the presentation and treatment of symptomatic breast cancer. Br J Cancer. 1999; 79(5-6):858-64. PMC: 2362673. DOI: 10.1038/sj.bjc.6690137. View

Richards M, Westcombe A, Love S, Littlejohns P, Ramirez A . Influence of delay on survival in patients with breast cancer: a systematic review. Lancet. 1999; 353(9159):1119-26. DOI: 10.1016/s0140-6736(99)02143-1. View

Sainsbury R, Johnston C, Haward B . Effect on survival of delays in referral of patients with breast-cancer symptoms: a retrospective analysis. Lancet. 1999; 353(9159):1132-5. DOI: 10.1016/s0140-6736(99)02374-0. View

Haddad N, Silva M . [Female mortality in reproductive age in the State of Sao Paulo, Brazil, 1991-1995: underlying causes of death and maternal mortality]. Rev Saude Publica. 2000; 34(1):64-70. DOI: 10.1590/s0034-89102000000100012. View

Rodriguez-Cuevas S, Macias C, Franceschi D, Labastida S . Breast carcinoma presents a decade earlier in Mexican women than in women in the United States or European countries. Cancer. 2001; 91(4):863-8. View

Montella M, Crispo A, DAiuto G, De Marco M, de Bellis G, Fabbrocini G . Determinant factors for diagnostic delay in operable breast cancer patients. Eur J Cancer Prev. 2001; 10(1):53-9. DOI: 10.1097/00008469-200102000-00006. View

Arndt V, Sturmer T, Stegmaier C, Ziegler H, Becker A, Brenner H . Provider delay among patients with breast cancer in Germany: a population-based study. J Clin Oncol. 2003; 21(8):1440-6. DOI: 10.1200/JCO.2003.08.071. View

Barber M, Jack W, Dixon J . Diagnostic delay in breast cancer. Br J Surg. 2004; 91(1):49-53. DOI: 10.1002/bjs.4436. View

Robertson R, Campbell N, Smith S, Donnan P, Sullivan F, Duffy R . Factors influencing time from presentation to treatment of colorectal and breast cancer in urban and rural areas. Br J Cancer. 2004; 90(8):1479-85. PMC: 2409724. DOI: 10.1038/sj.bjc.6601753. View

10.

Partridge A, Gelber S, Peppercorn J, Sampson E, Knudsen K, Laufer M . Web-based survey of fertility issues in young women with breast cancer. J Clin Oncol. 2004; 22(20):4174-83. DOI: 10.1200/JCO.2004.01.159. View

11.

Han W, Kim S, Park I, Kang D, Kim S, Youn Y . Young age: an independent risk factor for disease-free survival in women with operable breast cancer. BMC Cancer. 2004; 4:82. PMC: 545947. DOI: 10.1186/1471-2407-4-82. View

12.

Neal R, Allgar V . Sociodemographic factors and delays in the diagnosis of six cancers: analysis of data from the "National Survey of NHS Patients: Cancer". Br J Cancer. 2005; 92(11):1971-5. PMC: 2361785. DOI: 10.1038/sj.bjc.6602623. View

13.

Boulos S, Gadallah M, Neguib S, Essam E, Youssef A, Costa A . Breast screening in the emerging world: high prevalence of breast cancer in Cairo. Breast. 2005; 14(5):340-6. DOI: 10.1016/j.breast.2005.07.002. View

14.

Bleyer A, Barr R, Hayes-Lattin B, Thomas D, Ellis C, Anderson B . The distinctive biology of cancer in adolescents and young adults. Nat Rev Cancer. 2008; 8(4):288-98. DOI: 10.1038/nrc2349. View

15.

Knaul F, Nigenda G, Lozano R, Arreola-Ornelas H, Langer A, Frenk J . Breast cancer in Mexico: a pressing priority. Reprod Health Matters. 2008; 16(32):113-23. DOI: 10.1016/S0968-8080(08)32414-8. View

16.

Rezende M, Koch H, Figueiredo J, Thuler L . [Factors leading to delay in obtaining definitive diagnosis of suspicious lesions for breast cancer in a dedicated health unit in Rio de Janeiro]. Rev Bras Ginecol Obstet. 2009; 31(2):75-81. DOI: 10.1590/s0100-72032009000200005. View

17.

Schneider I, DOrsi E . [Five-year survival and prognostic factors in women with breast cancer in Santa Catarina State, Brazil]. Cad Saude Publica. 2009; 25(6):1285-96. DOI: 10.1590/s0102-311x2009000600011. View

18.

Bright K, Barghash M, Donach M, Gutierrez De la Barrera M, Schneider R, Formenti S . The role of health system factors in delaying final diagnosis and treatment of breast cancer in Mexico City, Mexico. Breast. 2011; 20 Suppl 2:S54-9. DOI: 10.1016/j.breast.2011.02.012. View

19.

Robles-Castillo J, Ruvalcaba-Limon E, Maffuz A, Rodriguez-Cuevas S . [Breast cancer in Mexican women under 40]. Ginecol Obstet Mex. 2011; 79(8):482-8. View

20.

Collins L, Marotti J, Gelber S, Cole K, Ruddy K, Kereakoglow S . Pathologic features and molecular phenotype by patient age in a large cohort of young women with breast cancer. Breast Cancer Res Treat. 2011; 131(3):1061-6. DOI: 10.1007/s10549-011-1872-9. View